Author

Lin Zeng

Chinese Academy of SciencesORCID 0009-0006-3824-9823Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Lin Zeng3 papers · Shanghai Jiao Tong University

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:scRNA-seq· 1 Approach:statistical model· 1

Frequent Co-Authors

Binyu ZhangiD· 1 shared Boxi Zhao· 1 shared Chunhao Long· 1 shared Guanyin Huang· 1 shared Hao YuiD· 1 shared Hui YangiD· 1 shared Jialing Liu· 1 shared Jian Zhang· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Binyu ZhangORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintAug 20, 2026

The HES1-SOD1 Antagonism Shapes Senescence Heterogeneity and Impacts Metastatic Relapse of Circulating Tumor Cells

Guanyin Huang, Xiaolong Xu, Binyu Zhang…·Xin Hong

This study identifies two HES1-expressing senescent CTC subpopulations with distinct metabolic and clinical outcomes, showing HES1-SOD1 antagonism influences metastatic relapse.

DOI 10.64898/2026.08.19.745859

𝕏 PostBluesky